Pier 70 Ventures

Pier 70 Ventures is a venture capital investment firm based in Seattle, Washington, founded in 2021. The firm focuses on funding disruptive technologies within the healthcare sector that have the potential to transform existing practices and improve outcomes. Pier 70 Ventures targets companies at various stages of development, including seed-stage, early-stage, and later-stage businesses, emphasizing innovation and significant impact within the healthcare industry.

Miller Adams

Co-Founder and Managing Partner

Robert Balk

Co-Founder and Venture Partner

Shaun Hawkins

Managing Partner

Preetha Ram

Senior Managing Director and General Partner, INpact Fund

6 past transactions

Flyte

Seed Round in 2024
Pelvital USA, Inc. is a privately held company based in Minneapolis, Minnesota, focused on restoring pelvic health and enhancing the quality of life for individuals suffering from pelvic floor disorders. Founded in 2016, the company is currently evaluating the Flyte system, an investigational medical device designed to strengthen and potentially heal the pelvic floor muscle system. This device employs a unique mechanotherapy technology, which has been shown to effectively heal and strengthen muscle systems. Through its innovative approach, Pelvital aims to provide significant improvements for patients dealing with pelvic floor issues.

PrīmSphera

Seed Round in 2023
PrīmSphera (fka Vital View Technologies) is a revolutionary sensor technology company pioneering break-through solutions to solve real-world challenges. Our vision is to create a contactless sensor platform to improve effective decision making by unlocking insights that are otherwise unavailable. With applications in defense, and food processing, PrīmSphera has selected Healthcare as a primary industry for the beachhead market. Founded as a catalyst to commercialize the research of Dr. Thomas Pratt at The University of Notre Dame, who is a pioneer in leveraging radio frequency polarization mode dispersion (RF-PMD) for a range of sensing applications. The name ‘PrīmSphera’ (Pryme-SFair-uh) embodies our mission to deliver pioneering solutions (‘Prīm’—meaning first) and highlights the unique spherical output of Dr. Thomas Pratt’s groundbreaking work. Today, PrīmSphera are actively developing its flagship product, a state-of-the-art connected solution for the hospital-at-home. This monitoring platform features a proprietary non-contact, at-home medical monitor that tracks fluid change over time. This provides early, actionable data to patients and clinicians to inform care plans.

KayoThera

Series A in 2023
KayoThera is a biotechnology company based in Princeton, New Jersey, focused on developing therapeutics for late-stage and metastatic cancers. Founded in 2019, the company aims to create first-in-class immuno- and targeted therapies that target a key enzyme responsible for protecting cancer cells, as well as depleting regulatory T-cells. This innovative approach seeks to enhance the effectiveness of existing treatments, such as chemotherapy and immunotherapy, thereby offering new hope to patients with previously incurable cancers. KayoThera's mission is centered on driving breakthroughs in cancer treatment and improving patient outcomes.

Community

Venture Round in 2023
Community is a social engagement platform that enables effective two-way communication between influencers and their audiences. It provides a unique 10-digit phone number that connects businesses, brands, public figures, and creators directly to their consumers. By facilitating interactions without the challenges of commercial interests, toxicity, and data privacy issues commonly found on social media, the platform allows a diverse range of users—including global brands, sports teams, artists, and small businesses—to engage with their audience on a personal level. This approach enhances communication and fosters meaningful relationships between influencers and their followers.

ZeroCarb LYFE

Venture Round in 2023
ZeroCarbLYFE is a food tech company with the mission to bring joy into healthy food. We invented multiple high proteins, and low/no carb foods that taste as good as or better than carb-loaded alternatives.

DocSpera

Series B in 2022
DocSpera is an integrated surgical coordination platform that enhances workflow efficiencies and patient care by streamlining synchronization across various sites and teams. Its proprietary technology automates pre-surgical coordination and facilitates real-time, secure case and image synchronization among surgeons, care teams, and device suppliers, utilizing electronic health record (EHR) data. The platform also provides real-time patient insights and operating room dashboards, enabling continuous monitoring of patients from the surgical decision point through recovery. Headquartered in Sunnyvale, California, DocSpera operates under Compliant Innovations Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.